Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 1 | $13,723 |
| Sells | 165 | $93,726,859 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 30 Oct 2024 18:04 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 28 Oct 2024 | Sale | 5,600 | 28.4933 | 159,562 | D |
| 30 Oct 2024 18:04 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 28 Oct 2024 | Sale | 650 | 29.111 | 18,922 | D |
| 22 Oct 2024 16:18 | ELVN | Enliven Therapeutics Inc | HEYMAN RICHARD A. | Director | 18 Oct 2024 | Sale | 817 | 30.003 | 24,512 | D |
| 22 Oct 2024 16:18 | ELVN | Enliven Therapeutics Inc | HEYMAN RICHARD A. | Director | 18 Oct 2024 | Sale | 753 | 30.0021 | 22,592 | I |
| 22 Oct 2024 16:17 | ELVN | Enliven Therapeutics Inc | COLLINS HELEN LOUISE | CHIEF MEDICAL OFFICER | 18 Oct 2024 | Sale | 816 | 30.003 | 24,482 | D |
| 22 Oct 2024 16:23 | ELVN | Enliven Therapeutics Inc | PATEL ANISH | CHIEF OPERATING OFFICER | 18 Oct 2024 | Sale | 716 | 30.0035 | 21,483 | I |
| 22 Oct 2024 16:22 | ELVN | Enliven Therapeutics Inc | LYSSIKATOS JOSEPH P | CHIEF SCIENTIFIC OFFICER | 18 Oct 2024 | Sale | 847 | 30.003 | 25,413 | I |
| 22 Oct 2024 16:21 | ELVN | Enliven Therapeutics Inc | KINTZ SAMUEL | PRESIDENT AND CEO | 18 Oct 2024 | Sale | 924 | 30.0029 | 27,723 | I |
| 22 Oct 2024 16:19 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 18 Oct 2024 | Sale | 814 | 30.003 | 24,422 | D |
| 17 Oct 2024 17:06 | ELVN | Enliven Therapeutics Inc | HEYMAN RICHARD A. | Director | 15 Oct 2024 | Sale | 1,270 | 27.6719 | 35,143 | D |
| 10 Oct 2024 20:38 | ELVN | Enliven Therapeutics Inc | KINTZ SAMUEL | PRESIDENT AND CEO | 09 Oct 2024 | Sale | 13,880 | 28.0746 | 389,675 | I |
| 10 Oct 2024 20:38 | ELVN | Enliven Therapeutics Inc | KINTZ SAMUEL | PRESIDENT AND CEO | 09 Oct 2024 | Sale | 2,830 | 28.5264 | 80,730 | I |
| 10 Oct 2024 20:39 | ELVN | Enliven Therapeutics Inc | LYSSIKATOS JOSEPH P | CHIEF SCIENTIFIC OFFICER | 09 Oct 2024 | Sale | 34,289 | 28.1199 | 964,203 | I |
| 10 Oct 2024 20:39 | ELVN | Enliven Therapeutics Inc | LYSSIKATOS JOSEPH P | CHIEF SCIENTIFIC OFFICER | 09 Oct 2024 | Sale | 3,589 | 28.5199 | 102,358 | I |
| 10 Oct 2024 20:38 | ELVN | Enliven Therapeutics Inc | KINTZ SAMUEL | PRESIDENT AND CEO | 08 Oct 2024 | Sale | 13,167 | 27.9546 | 368,078 | I |
| 10 Oct 2024 20:38 | ELVN | Enliven Therapeutics Inc | KINTZ SAMUEL | PRESIDENT AND CEO | 08 Oct 2024 | Sale | 100 | 28.51 | 2,851 | I |
| 10 Oct 2024 20:36 | ELVN | Enliven Therapeutics Inc | BALLAL RAHUL D. | Director | 08 Oct 2024 | Sale | 10,420 | 28.1725 | 293,557 | D |
| 10 Oct 2024 20:39 | ELVN | Enliven Therapeutics Inc | LYSSIKATOS JOSEPH P | CHIEF SCIENTIFIC OFFICER | 08 Oct 2024 | Sale | 13,167 | 27.9618 | 368,173 | I |
| 10 Oct 2024 20:39 | ELVN | Enliven Therapeutics Inc | LYSSIKATOS JOSEPH P | CHIEF SCIENTIFIC OFFICER | 08 Oct 2024 | Sale | 100 | 28.51 | 2,851 | I |
| 08 Oct 2024 18:58 | ELVN | Enliven Therapeutics Inc | LYSSIKATOS JOSEPH P | CHIEF SCIENTIFIC OFFICER | 07 Oct 2024 | Sale | 2,707 | 27.6051 | 74,727 | I |
| 08 Oct 2024 18:57 | ELVN | Enliven Therapeutics Inc | KINTZ SAMUEL | PRESIDENT AND CEO | 07 Oct 2024 | Sale | 2,730 | 27.5 | 75,075 | I |
| 08 Oct 2024 18:56 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 07 Oct 2024 | Sale | 1,270 | 27.5081 | 34,935 | D |
| 08 Oct 2024 18:58 | ELVN | Enliven Therapeutics Inc | LYSSIKATOS JOSEPH P | CHIEF SCIENTIFIC OFFICER | 04 Oct 2024 | Sale | 7,522 | 27.5109 | 206,937 | I |
| 08 Oct 2024 18:57 | ELVN | Enliven Therapeutics Inc | KINTZ SAMUEL | PRESIDENT AND CEO | 04 Oct 2024 | Sale | 12,206 | 27.5104 | 335,792 | I |
| 08 Oct 2024 18:56 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 04 Oct 2024 | Sale | 10,218 | 27.5082 | 281,079 | D |
| 08 Oct 2024 18:54 | ELVN | Enliven Therapeutics Inc | HEYMAN RICHARD A. | Director | 04 Oct 2024 | Sale | 2,825 | 27.5057 | 77,704 | D |
| 03 Oct 2024 18:43 | ELVN | Enliven Therapeutics Inc | HEYMAN RICHARD A. | Director | 01 Oct 2024 | Sale | 518 | 27.5373 | 14,264 | D |
| 03 Oct 2024 18:47 | ELVN | Enliven Therapeutics Inc | LYSSIKATOS JOSEPH P | CHIEF SCIENTIFIC OFFICER | 01 Oct 2024 | Sale | 527 | 27.5372 | 14,512 | I |
| 03 Oct 2024 18:45 | ELVN | Enliven Therapeutics Inc | KINTZ SAMUEL | PRESIDENT AND CEO | 01 Oct 2024 | Sale | 526 | 27.5371 | 14,485 | I |
| 03 Oct 2024 18:44 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 01 Oct 2024 | Sale | 521 | 27.5372 | 14,347 | D |
| 01 Oct 2024 19:53 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 30 Sep 2024 | Sale | 2,000 | 25.3338 | 50,668 | D |
| 01 Oct 2024 19:53 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 27 Sep 2024 | Sale | 4,250 | 24.2732 | 103,161 | D |
| 18 Sep 2024 16:17 | ELVN | Enliven Therapeutics Inc | HEYMAN RICHARD A. | Director | 16 Sep 2024 | Sale | 1,270 | 22.408 | 28,458 | D |
| 03 Sep 2024 17:43 | ELVN | Enliven Therapeutics Inc | LYSSIKATOS JOSEPH P | CHIEF SCIENTIFIC OFFICER | 29 Aug 2024 | Sale | 50 | 23.08 | 1,154 | I |
| 03 Sep 2024 17:43 | ELVN | Enliven Therapeutics Inc | LYSSIKATOS JOSEPH P | CHIEF SCIENTIFIC OFFICER | 29 Aug 2024 | Sale | 11,950 | 22.4843 | 268,687 | I |
| 29 Aug 2024 18:36 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 27 Aug 2024 | Sale | 4,250 | 22.5369 | 95,782 | D |
| 28 Aug 2024 19:48 | ELVN | Enliven Therapeutics Inc | KINTZ SAMUEL | PRESIDENT AND CEO | 26 Aug 2024 | Sale | 12,000 | 22.8932 | 274,718 | I |
| 19 Aug 2024 19:49 | ELVN | Enliven Therapeutics Inc | HEYMAN RICHARD A. | Director | 15 Aug 2024 | Sale | 620 | 23.7027 | 14,696 | D |
| 19 Aug 2024 19:49 | ELVN | Enliven Therapeutics Inc | HEYMAN RICHARD A. | Director | 15 Aug 2024 | Sale | 650 | 22.8162 | 14,831 | D |
| 02 Aug 2024 19:26 | ELVN | Enliven Therapeutics Inc | LYSSIKATOS JOSEPH P | CHIEF SCIENTIFIC OFFICER | 31 Jul 2024 | Sale | 3,099 | 27.5571 | 85,399 | I |
| 02 Aug 2024 19:25 | ELVN | Enliven Therapeutics Inc | KINTZ SAMUEL | PRESIDENT AND CEO | 31 Jul 2024 | Sale | 2,270 | 27.5573 | 62,555 | I |
| 02 Aug 2024 19:22 | ELVN | Enliven Therapeutics Inc | HEYMAN RICHARD A. | Director | 31 Jul 2024 | Sale | 1,702 | 27.5059 | 46,815 | D |
| 02 Aug 2024 19:22 | ELVN | Enliven Therapeutics Inc | HEYMAN RICHARD A. | Director | 31 Jul 2024 | Sale | 649 | 27.5 | 17,848 | I |
| 02 Aug 2024 19:23 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 31 Jul 2024 | Sale | 991 | 27.5287 | 27,281 | D |
| 31 Jul 2024 19:31 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 29 Jul 2024 | Sale | 61 | 27.4431 | 1,674 | D |
| 31 Jul 2024 19:31 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 29 Jul 2024 | Sale | 5,189 | 26.6676 | 138,378 | D |
| 31 Jul 2024 19:33 | ELVN | Enliven Therapeutics Inc | LYSSIKATOS JOSEPH P | CHIEF SCIENTIFIC OFFICER | 29 Jul 2024 | Sale | 203 | 27.4333 | 5,569 | I |
| 31 Jul 2024 19:33 | ELVN | Enliven Therapeutics Inc | LYSSIKATOS JOSEPH P | CHIEF SCIENTIFIC OFFICER | 29 Jul 2024 | Sale | 11,797 | 26.6855 | 314,809 | I |
| 29 Jul 2024 17:39 | ELVN | Enliven Therapeutics Inc | KINTZ SAMUEL | PRESIDENT AND CEO | 25 Jul 2024 | Sale | 43 | 25.8295 | 1,111 | I |
| 29 Jul 2024 17:39 | ELVN | Enliven Therapeutics Inc | KINTZ SAMUEL | PRESIDENT AND CEO | 25 Jul 2024 | Sale | 8,164 | 25.1004 | 204,920 | I |
| 29 Jul 2024 17:39 | ELVN | Enliven Therapeutics Inc | KINTZ SAMUEL | PRESIDENT AND CEO | 25 Jul 2024 | Sale | 3,793 | 24.53 | 93,042 | I |
| 16 Jul 2024 17:37 | ELVN | Enliven Therapeutics Inc | PATEL ANISH | CHIEF OPERATING OFFICER | 16 Jul 2024 | Sale | 1,547 | 25.0111 | 38,692 | I |
| 17 Jul 2024 19:25 | ELVN | Enliven Therapeutics Inc | HEYMAN RICHARD A. | Director | 15 Jul 2024 | Sale | 1,270 | 24.8006 | 31,497 | D |
| 16 Jul 2024 17:37 | ELVN | Enliven Therapeutics Inc | PATEL ANISH | CHIEF OPERATING OFFICER | 15 Jul 2024 | Sale | 30,978 | 25.0513 | 776,039 | I |
| 16 Jul 2024 17:34 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 12 Jul 2024 | Sale | 3,000 | 25.065 | 75,195 | D |
| 16 Jul 2024 17:37 | ELVN | Enliven Therapeutics Inc | PATEL ANISH | CHIEF OPERATING OFFICER | 12 Jul 2024 | Sale | 17,475 | 25.0698 | 438,095 | I |
| 03 Jul 2024 16:31 | ELVN | Enliven Therapeutics Inc | LYSSIKATOS JOSEPH P | CHIEF SCIENTIFIC OFFICER | 01 Jul 2024 | Sale | 12,000 | 22.8947 | 274,736 | I |
| 01 Jul 2024 20:03 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 27 Jun 2024 | Sale | 1,140 | 23.4308 | 26,711 | D |
| 01 Jul 2024 20:03 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 27 Jun 2024 | Sale | 1,830 | 22.5756 | 41,313 | D |
| 01 Jul 2024 20:03 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 27 Jun 2024 | Sale | 1,280 | 21.7946 | 27,897 | D |
| 27 Jun 2024 16:35 | ELVN | Enliven Therapeutics Inc | KINTZ SAMUEL | PRESIDENT AND CEO | 25 Jun 2024 | Sale | 578 | 22.296 | 12,887 | I |
| 27 Jun 2024 16:35 | ELVN | Enliven Therapeutics Inc | KINTZ SAMUEL | PRESIDENT AND CEO | 25 Jun 2024 | Sale | 11,422 | 21.6262 | 247,014 | I |
| 20 Jun 2024 19:20 | ELVN | Enliven Therapeutics Inc | HEYMAN RICHARD A. | Director | 17 Jun 2024 | Sale | 1,270 | 21.4787 | 27,278 | D |
| 10 Jun 2024 18:46 | ELVN | Enliven Therapeutics Inc | PATEL ANISH | CHIEF OPERATING OFFICER | 06 Jun 2024 | Sale | 1,133 | 20.0551 | 22,722 | D |
| 31 May 2024 16:05 | ELVN | Enliven Therapeutics Inc | LYSSIKATOS JOSEPH P | CHIEF SCIENTIFIC OFFICER | 29 May 2024 | Sale | 2,123 | 22.5212 | 47,813 | D |
| 31 May 2024 16:05 | ELVN | Enliven Therapeutics Inc | LYSSIKATOS JOSEPH P | CHIEF SCIENTIFIC OFFICER | 29 May 2024 | Sale | 9,877 | 21.564 | 212,988 | D |
| 30 May 2024 17:56 | ELVN | Enliven Therapeutics Inc | KINTZ SAMUEL | PRESIDENT AND CEO | 28 May 2024 | Sale | 100 | 24.34 | 2,434 | D |
| 30 May 2024 17:56 | ELVN | Enliven Therapeutics Inc | KINTZ SAMUEL | PRESIDENT AND CEO | 28 May 2024 | Sale | 5,219 | 23.5715 | 123,020 | D |
| 30 May 2024 17:56 | ELVN | Enliven Therapeutics Inc | KINTZ SAMUEL | PRESIDENT AND CEO | 28 May 2024 | Sale | 6,681 | 22.8643 | 152,756 | D |
| 30 May 2024 17:54 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 28 May 2024 | Sale | 10 | 24.34 | 243 | D |
| 30 May 2024 17:54 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 28 May 2024 | Sale | 2,334 | 23.4184 | 54,659 | D |
| 30 May 2024 17:54 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 28 May 2024 | Sale | 1,906 | 22.89 | 43,628 | D |
| 20 May 2024 19:46 | ELVN | Enliven Therapeutics Inc | HEYMAN RICHARD A. | Director | 16 May 2024 | Sale | 1,270 | 23.7399 | 30,150 | D |
| 20 May 2024 17:00 | ELVN | Enliven Therapeutics Inc | ORBIMED ADVISORS LLC | Director , 10% | 16 May 2024 | Sale | 1,000,000 | 22.14 | 22,140,000 | I |
| 20 May 2024 17:00 | ELVN | Enliven Therapeutics Inc | ORBIMED ADVISORS LLC | Director , 10% | 16 May 2024 | Sale | 33,300 | 22.14 | 737,262 | I |
| 20 May 2024 17:03 | ELVN | Enliven Therapeutics Inc | GUPTA RISHI | Director , 10% | 16 May 2024 | Sale | 1,000,000 | 22.14 | 22,140,000 | I |
| 20 May 2024 17:03 | ELVN | Enliven Therapeutics Inc | GUPTA RISHI | Director , 10% | 16 May 2024 | Sale | 33,300 | 22.14 | 737,262 | I |
| 16 May 2024 19:29 | ELVN | Enliven Therapeutics Inc | PATEL ANISH | CHIEF OPERATING OFFICER | 14 May 2024 | Sale | 1,107 | 25 | 27,675 | D |
| 13 May 2024 19:35 | ELVN | Enliven Therapeutics Inc | PATEL ANISH | CHIEF OPERATING OFFICER | 09 May 2024 | Sale | 260 | 25.0596 | 6,515 | D |
| 08 May 2024 20:40 | ELVN | Enliven Therapeutics Inc | PATEL ANISH | CHIEF OPERATING OFFICER | 06 May 2024 | Sale | 4,875 | 22.7219 | 110,769 | D |
| 07 May 2024 18:58 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 03 May 2024 | Sale | 1,000 | 22.5 | 22,500 | D |
| 01 May 2024 19:02 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 29 Apr 2024 | Sale | 3,250 | 16.9737 | 55,165 | D |
| 01 May 2024 19:04 | ELVN | Enliven Therapeutics Inc | LYSSIKATOS JOSEPH P | CHIEF SCIENTIFIC OFFICER | 29 Apr 2024 | Sale | 1,013 | 18.4823 | 18,723 | D |
| 01 May 2024 19:04 | ELVN | Enliven Therapeutics Inc | LYSSIKATOS JOSEPH P | CHIEF SCIENTIFIC OFFICER | 29 Apr 2024 | Sale | 10,987 | 17.8634 | 196,265 | D |
| 29 Apr 2024 18:50 | ELVN | Enliven Therapeutics Inc | KINTZ SAMUEL | PRESIDENT AND CEO | 25 Apr 2024 | Sale | 12,000 | 16.8917 | 202,700 | D |
| 15 Apr 2024 19:03 | ELVN | Enliven Therapeutics Inc | HEYMAN RICHARD A. | Director | 15 Apr 2024 | Sale | 80 | 20.6773 | 1,654 | D |
| 15 Apr 2024 19:03 | ELVN | Enliven Therapeutics Inc | HEYMAN RICHARD A. | Director | 15 Apr 2024 | Sale | 1,190 | 19.9403 | 23,729 | D |
| 15 Apr 2024 19:04 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 11 Apr 2024 | Sale | 10,223 | 25.0386 | 255,970 | D |
| 15 Apr 2024 19:04 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 11 Apr 2024 | Sale | 3,777 | 23.8759 | 90,179 | D |
| 15 Apr 2024 19:05 | ELVN | Enliven Therapeutics Inc | KINTZ SAMUEL | PRESIDENT AND CEO | 11 Apr 2024 | Sale | 47,709 | 25.0414 | 1,194,700 | D |
| 15 Apr 2024 19:06 | ELVN | Enliven Therapeutics Inc | LYSSIKATOS JOSEPH P | CHIEF SCIENTIFIC OFFICER | 11 Apr 2024 | Sale | 30,000 | 25.0444 | 751,332 | D |
| 15 Apr 2024 19:06 | ELVN | Enliven Therapeutics Inc | PATEL ANISH | CHIEF OPERATING OFFICER | 11 Apr 2024 | Sale | 17,500 | 25.0342 | 438,098 | D |
| 15 Apr 2024 19:03 | ELVN | Enliven Therapeutics Inc | HEYMAN RICHARD A. | Director | 11 Apr 2024 | Sale | 649 | 25 | 16,225 | I |
| 15 Apr 2024 19:02 | ELVN | Enliven Therapeutics Inc | COLLINS HELEN LOUISE | CHIEF MEDICAL OFFICER | 11 Apr 2024 | Sale | 20,000 | 25.0739 | 501,478 | D |
| 15 Apr 2024 19:03 | ELVN | Enliven Therapeutics Inc | HEYMAN RICHARD A. | Director | 11 Apr 2024 | Sale | 5,045 | 25.0306 | 126,279 | D |
| 12 Apr 2024 18:23 | ELVN | Enliven Therapeutics Inc | BALLAL RAHUL D. | Director | 11 Apr 2024 | Sale | 3,068 | 25.2094 | 77,342 | D |
| 12 Apr 2024 18:23 | ELVN | Enliven Therapeutics Inc | BALLAL RAHUL D. | Director | 11 Apr 2024 | Sale | 20,032 | 24.9951 | 500,702 | D |
| 12 Apr 2024 18:23 | ELVN | Enliven Therapeutics Inc | BALLAL RAHUL D. | Director | 11 Apr 2024 | Sale | 30,300 | 23.1361 | 701,024 | D |
| 12 Apr 2024 18:23 | ELVN | Enliven Therapeutics Inc | BALLAL RAHUL D. | Director | 10 Apr 2024 | Sale | 13,600 | 21.0106 | 285,744 | D |
| 10 Apr 2024 20:35 | ELVN | Enliven Therapeutics Inc | PATEL ANISH | CHIEF OPERATING OFFICER | 08 Apr 2024 | Sale | 544 | 19.3979 | 10,552 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)